64778 Federal Register / Vol. 69, No. 215 / Monday, November 8, 2004 / Notices 

conference bridge number is (877) 368–

9836 and the participant pass code is 

852136. For financial, grants 

management, or budget assistance, 

contact: Angie Tuttle, Grants 

Management Specialist, CDC 

Procurement and Grants Office, 2920 

Brandywine Road, Atlanta, GA 30341. 

Telephone: (770) 488–2719. E-mail: 

AEN4@cdc.gov.

VIII. Other Information 

This and other CDC funding 

opportunity announcements can be 

found on the CDC Web site, Internet 

address: www.cdc.gov. Click on 

‘‘Funding’’ then ‘‘Grants and 

Cooperative Agreements.’’

Dated: November 2, 2004. 

William P. Nichols, 

Acting Director, Procurement and Grants 

Office, Centers for Disease Control and 

Prevention.

[FR Doc. 04–24809 Filed 11–5–04; 8:45 am] 

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES

Food and Drug Administration

Advisory Committee; Renewals

AGENCY: Food and Drug Administration, 

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug 

Administration (FDA) is announcing the 

renewal of certain FDA advisory 

committees by the Commissioner of 

Food and Drugs (the Commissioner). 

The Commissioner has determined that 

it is in the public interest to renew the 

charters of the committees listed in table 

1 of this document for an additional 2 

years beyond charter expiration date. 

The new charters will be in effect until 

the dates of expiration listed in table 1. 

This notice is issued under the Federal 

Advisory Committee Act of October 6, 

1972 (Public Law 92–463 (5 U.S.C. app. 

2)).

DATES: Authority for these committees 

will expire on the dates indicated in 

table 1 of this document unless the 

Commissioner formally determines that 

renewal is in the public interest.

TABLE 1.

Name of committee Date of expiration 

Anesthetic and Life Support Drugs Advisory Committee ......................................................................................................... May 1, 2006.

Blood Products Advisory Committee ........................................................................................................................................ May 13, 2006.

Pulmonary-Allergy Drugs Advisory Committee ......................................................................................................................... May 30, 2006.

Drug Safety and Risk Management Advisory Committee ........................................................................................................ May 31, 2006.

Science Advisory Board to the National Center for Toxicological Research ........................................................................... June 2, 2006.

Peripheral and Central Nervous System Drugs Advisory Committee ...................................................................................... June 4, 2006.

Psychopharmacologic Drugs Advisory Committee ................................................................................................................... June 4, 2006.

Transmissible Spongiform Encephalopathies Advisory Committee ......................................................................................... June 9, 2006.

Science Board to the Food and Drug Administration ............................................................................................................... June 26, 2006.

Allergenic Products Advisory Committee .................................................................................................................................. July 9, 2006.

Cardiovascular and Renal Drugs Advisory Committee ............................................................................................................ August 27, 2006.

Endocrinologic and Metabolic Drugs Advisory Committee ....................................................................................................... August 27, 2006.

Oncologic Drugs Advisory Committee ...................................................................................................................................... September 1, 2006.

Anti-Infective Drugs Advisory Committee ................................................................................................................................. October 7, 2006.

Dermatologic and Ophthalmic Drugs Advisory Committee ...................................................................................................... October 7, 2006.

Cellular, Tissue, and Gene Therapies Advisory Committee (formerly Biological Response Modifiers Advisory Committee) October 28, 2006.

FOR FURTHER INFORMATION CONTACT:

Linda A. Sherman, Advisory Committee 

Oversight and Management Staff (HF–

4), Food and Drug Administration, 5600 

Fishers Lane, Rockville, MD 20857, 

301–827–1220.

Dated: October 29, 2004.

Sheila Dearybury Walcoff,

Associate Commissioner for External 

Relations.

[FR Doc. 04–24842 Filed 11–5–04; 8:45 am]

BILLING CODE 4160–01–S

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Research 

Resources; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Center for 

Research Resources Special Emphasis Panel 

Clinical Research. 

Date: November 17–18, 2004. 

Time: November 17, 2004, 8 a.m. to 

Adjournment. 

Agenda: To review and evaluate grant 

applications. 

Place: Omni Charlottesville Hotel, 235 

West Main Street, Charlottesville, VA 22902. 

Contact Person: Carol Lambert, PhD, 

Scientific Review Administrator, Office of 

Review, National Institutes of Health, NCRR, 

6701 Democracy Blvd., 1 Democracy Plaza, 

Room 1076, MSC 4874, Bethesda, MD 20892, 

(301) 435–0814, lambert@mail.nih.gov.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research; 93.371, Biomedical 

Technology; 93.389, Research Infrastructure, 

93.306, 93.333, National Institutes of Health, 

HHS.)

Dated: October 28, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–24795 Filed 11–5–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Environmental 

Health Sciences; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as

Federal Register / Vol. 69, No. 215 / Monday, November 8, 2004 / Notices 64779

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Institute of 

Environmental Health Sciences Special 

Emphasis Panel K25 Review. 

Date: December 6, 2004–6, 2005. 

Time: 1 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: NIEHS/National Institutes of Health, 

Building 4401, East Campus, 79 T.W. 

Alexander Drive, Research Triangle Park, NC 

27709, (Telephone Conference Call). 

Contact Person: Linda K. Bass, PhD, 

Scientific Review Administrator, Scientific 

Review Branch, Division of Extramural 

Research & Training, Nat. Institute of 

Environmental Hlth. Sciences, P.O. Box 

12233, MD EC–30, Research Triangle Park, 

NC 27709, (919) 541–1307.

Name of Committee: National Institute of 

Environmental Health Sciences Special 

Emphasis Panel K23 Review. 

Date: December 6, 2004. 

Time: 2 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: NIEHS/National Institutes of Health, 

Building 4401, East Campus, 79 T.W. 

Alexander Drive, Research Triangle Park, NC 

27709, (Telephone Conference Call). 

Contact Person: Linda K. Bass, PhD, 

Scientific Review Administrator, Scientific 

Review Branch, Division of Extramural 

Research & Training, Nat. Institute of 

Environmental Hlth. Sciences, P.O. Box 

12233, MD EC–30, Research Triangle Park, 

NC 27709, (919) 541–1307.

Name of Committee: National Institute of 

Environmental Health Sciences Special 

Emphasis Panel K08 Review. 

Date: December 6, 2004. 

Time: 3 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: NIEHS/National Institutes of Health, 

Building 4401, East Campus, 79 T.W. 

Alexander Drive, Research Triangle Park, NC 

27709, (Telephone Conference Call). 

Contact Person: Linda K. Bass, PhD, 

Scientific Review Administrator, Scientific 

Review Branch, Division of Extramural 

Research & Training, Nat. Institute of 

Environmental Hlth. Sciences, P.O. Box 

12233, MD EC–30, Research Triangle Park, 

NC 27709, (919) 541–1307.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.115, Biometry and Risk 

Estimation—Health Risks from 

Environmental Exposures; 93.142, NIEHS 

Hazardous Waste Worker Health and Safety 

Training; 93.143, NIEHS Superfund 

Hazardous Substances—Basic Research and 

Education, 93.894, Resources and Manpower 

Development in the Environmental Health 

Sciences; 93.113, Biological Response to 

Environmental Health Hazards; 93.114, 

Applied Toxicological Research and Testing, 

National Institutes of Health, HHS.)

Dated: October 28, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–24792 Filed 11–5–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Institute on 

Aging Special Emphasis Panel, Pathology 

Rodent Colonies. 

Date: November 17, 2004. 

Time: 11 a.m. to 12 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Ave., 

2C212, Bethesda, MD 20892, (Telephone 

Conference Call). 

Contact Person: Alfonso R. Latoni, PhD, 

Scientific Review Administrator, Scientific 

Review Office, National Institute on Aging, 

National Institutes of Health, 7201 Wisconsin 

Avenue, Room 2C212, Bethesda, MD 20892, 

(301) 496–9666, latonia@mail.nih.gov.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS.)

Dated: October 28, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–24793 Filed 11–5–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Environmental 

Health Sciences; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Institute of 

Environmental Health Sciences Special 

Emphasis Panel Training Grants. 

Date: November 16, 2004. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: NIEHS/National Institutes of Health, 

Building 4401, East Campus, 79 T.W. 

Alexander Drive, Research Triangle Park, NC 

27709, (Telephone Conference Call). 

Contact Person: Leroy Worth, PhD, 

Scientific Review Administrator, Scientific 

Review Branch, Division of Extramural 

Research and Training, Nat. Institute of 

Environmental Health Sciences, P.O. Box 

12233, MD EC–30/Room 3171, Research 

Triangle Park, NC 27709, 919/541–0670, 

worth@niehs.nih.gov.

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.115, Biometry and Risk 

Estimation—Health Risks from 

Environmental Exposures; 93.142, NIEHS 

Hazardous Waste Worker Health and Safety 

Training; 93.143, NIEHS Superfund 

Hazardous Substances—Basic Research and 

Education; 93.894, Resources and Manpower 

Development in the Environmental Health 

Sciences; 93.113, Biological Response to 

Environmental Health Hazards; 93.114, 

Applied Toxicological Research and Testing. 

National Institutes of Health, HHS.)

Dated: October 28, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–24796 Filed 11–5–04; 8:45 am] 

BILLING CODE 4140–01–M